N1-(5-Deoxy-1,2-O-isopropylidene-alpha-D-xylofuranose)-5-(N8-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine)

ID: ALA4280262

Chembl Id: CHEMBL4280262

PubChem CID: 145979000

Max Phase: Preclinical

Molecular Formula: C31H47N3O4

Molecular Weight: 525.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)O[C@H]2O[C@H](CNCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)[C@H](O)[C@H]2O1

Standard InChI:  InChI=1S/C31H47N3O4/c1-31(2)37-29-28(35)26(36-30(29)38-31)21-32-19-13-7-5-3-4-6-8-14-20-33-27-22-15-9-11-17-24(22)34-25-18-12-10-16-23(25)27/h9,11,15,17,26,28-30,32,35H,3-8,10,12-14,16,18-21H2,1-2H3,(H,33,34)/t26-,28+,29-,30-/m1/s1

Standard InChI Key:  BHLHCOHMQNAMGW-RRFVUZEHSA-N

Alternative Forms

  1. Parent:

    ALA4280262

    ---

Associated Targets(non-human)

Bche Butyrylcholinesterase (210 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ache Acetylcholinesterase (1323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 525.73Molecular Weight (Monoisotopic): 525.3567AlogP: 5.47#Rotatable Bonds: 14
Polar Surface Area: 84.87Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.00CX Basic pKa: 9.69CX LogP: 5.73CX LogD: 2.21
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: 0.20

References

1. Lopes JPB, Silva L, da Costa Franarin G, Antonio Ceschi M, Seibert Lüdtke D, Ferreira Dantas R, de Salles CMC, Paes Silva-Jr F, Roberto Senger M, Alvim Guedes I, Emmanuel Dardenne L..  (2018)  Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives.,  26  (20): [PMID:30340901] [10.1016/j.bmc.2018.10.003]
2. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source